| Year |
Citation |
Score |
| 2023 |
Dolgalev I, Zhou H, Murrell N, Le H, Sakellaropoulos T, Coudray N, Zhu K, Vasudevaraja V, Yeaton A, Goparaju C, Li Y, Sulaiman I, Tsay JJ, Meyn P, Mohamed H, et al. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nature Communications. 14: 6764. PMID 37938580 DOI: 10.1038/s41467-023-42327-x |
0.535 |
|
| 2023 |
Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Dolgalev I, et al. Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 3912. PMID 37400453 DOI: 10.1038/s41467-023-39680-2 |
0.525 |
|
| 2023 |
Davalos V, Lovell CD, Von Itter R, Dolgalev I, Agrawal P, Baptiste G, Kahler DJ, Sokolova E, Moran S, Piqué L, Vega-Saenz de Miera E, Fontanals-Cirera B, Karz A, Tsirigos A, Yun C, et al. An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma. Nature Communications. 14: 1867. PMID 37015919 DOI: 10.1038/s41467-023-36967-2 |
0.531 |
|
| 2023 |
Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Dolgalev I, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 797. PMID 36781852 DOI: 10.1038/s41467-023-36296-4 |
0.572 |
|
| 2022 |
Maiti G, Monteiro de Barros MR, Hu N, Dolgalev I, Roshan M, Foster JW, Tsirigos A, Wahlin KJ, Chakravarti S. Single cell RNA-seq of human cornea organoids identifies cell fates of a developing immature cornea. Pnas Nexus. 1: pgac246. PMID 36712326 DOI: 10.1093/pnasnexus/pgac246 |
0.532 |
|
| 2022 |
Yeaton A, Cayanan G, Loghavi S, Dolgalev I, Leddin EM, Loo CE, Torabifard H, Nicolet D, Wang J, Corrigan K, Paraskevopoulou V, Starczynowski DT, Wang E, Abdel-Wahab O, Viny AD, et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discovery. PMID 35924979 DOI: 10.1158/2159-8290.CD-21-1146 |
0.633 |
|
| 2022 |
Zacharioudakis E, Agianian B, Kumar Mv V, Biris N, Garner TP, Rabinovich-Nikitin I, Ouchida AT, Margulets V, Nordstrøm LU, Riley JS, Dolgalev I, Chen Y, Wittig AJH, Pekson R, Mathew C, et al. Modulating mitofusins to control mitochondrial function and signaling. Nature Communications. 13: 3775. PMID 35798717 DOI: 10.1038/s41467-022-31324-1 |
0.452 |
|
| 2022 |
Moubarak RS, de Pablos-Aragoneses A, Ortiz-Barahona V, Gong Y, Gowen M, Dolgalev I, Shadaloey SAA, Argibay D, Karz A, Von Itter R, Vega-Sáenz de Miera EC, Sokolova E, Darvishian F, Tsirigos A, Osman I, et al. The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis. Science Advances. 8: eabi7127. PMID 35179962 DOI: 10.1126/sciadv.abi7127 |
0.541 |
|
| 2021 |
Akhmetzyanova I, Aaron T, Galbo P, Tikhonova A, Dolgalev I, Tanaka M, Aifantis I, Zheng D, Zang X, Fooksman D. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα. Blood Advances. 5: 3592-3608. PMID 34550328 DOI: 10.1182/bloodadvances.2021005327 |
0.521 |
|
| 2021 |
Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga LA, Zeck B, Lopez De Rodas Gregorio M, Dowling CM, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, et al. Targeting the Atf7ip-Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity. Cancer Immunology Research. PMID 34462284 DOI: 10.1158/2326-6066.CIR-21-0543 |
0.548 |
|
| 2021 |
Deng J, Thennavan A, Dolgalev I, Chen T, Li J, Marzio A, Poirier JT, Peng D, Bulatovic M, Mukhopadhyay S, Silver H, Papadopoulos E, Pyon V, Thakurdin C, Han H, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer. Nature Cancer. 2: 503-514. PMID 34142094 DOI: 10.1038/s43018-021-00208-6 |
0.465 |
|
| 2020 |
Ma C, Witkowski MT, Harris J, Dolgalev I, Sreeram S, Qian W, Tong J, Chen X, Aifantis I, Chen W. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche. Science Advances. 6. PMID 33127669 DOI: 10.1126/sciadv.aba5536 |
0.532 |
|
| 2020 |
Witkowski MT, Dolgalev I, Evensen NA, Ma C, Chambers T, Roberts KG, Sreeram S, Dai Y, Tikhonova AN, Lasry A, Qu C, Pei D, Cheng C, Robbins GA, Pierro J, et al. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. PMID 32470390 DOI: 10.1016/J.Ccell.2020.04.015 |
0.656 |
|
| 2020 |
Scortegagna M, Hockemeyer K, Dolgalev I, Poźniak J, Rambow F, Li Y, Feng Y, Tinoco R, Otero DC, Zhang T, Brown K, Bosenberg M, Bradley LM, Marine JC, Aifantis I, et al. Siah2 control of T-regulatory cells limits anti-tumor immunity. Nature Communications. 11: 99. PMID 31911617 DOI: 10.1038/S41467-019-13826-7 |
0.369 |
|
| 2019 |
Zhang S, Dolgalev I, Zhang T, Ran H, Levine DA, Neel BG. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nature Communications. 10: 5367. PMID 31772167 DOI: 10.1038/S41467-019-13116-2 |
0.356 |
|
| 2019 |
Schwartz CJ, Dolgalev I, Vasudevaraja V, Kelly S, Heguy A, Snuderl M, Cotzia P, Jour G, Darvishian F. Revisiting multifocal breast Cancer: a Clonality study of ductal carcinoma using whole exome sequencing. Human Pathology. PMID 31704365 DOI: 10.1016/J.Humpath.2019.08.021 |
0.32 |
|
| 2019 |
Floristán A, Morales L, Hanniford D, Martinez C, Castellano-Sanz E, Dolgalev I, Ulloa-Morales A, Vega-Saenz de Miera E, Moran U, Darvishian F, Osman I, Kirchhoff T, Hernando E. Functional analysis of RPS27 mutations and expression in melanoma. Pigment Cell & Melanoma Research. PMID 31663663 DOI: 10.1111/Pcmr.12841 |
0.371 |
|
| 2019 |
Guillamot M, Ouazia D, Dolgalev I, Yeung ST, Kourtis N, Dai Y, Corrigan K, Zea-Redondo L, Saraf A, Florens L, Washburn MP, Tikhonova AN, Malumbres M, Gong Y, Tsirigos A, et al. The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation. Nature Immunology. PMID 31406379 DOI: 10.1038/S41590-019-0454-6 |
0.65 |
|
| 2019 |
Tikhonova AN, Dolgalev I, Hu H, Sivaraj KK, Hoxha E, Cuesta-Domínguez Á, Pinho S, Akhmetzyanova I, Gao J, Witkowski M, Guillamot M, Gutkin MC, Zhang Y, Marier C, Diefenbach C, et al. Author Correction: The bone marrow microenvironment at single-cell resolution. Nature. PMID 31296938 DOI: 10.1038/S41586-019-1394-X |
0.633 |
|
| 2019 |
Hundeyin M, Kurz E, Mishra A, Kochen Rossi JA, Liudahl SM, Leis KR, Mehrotra H, Kim M, Torres LE, Ogunsakin A, Link J, Sears RC, Sivagnanam S, Goecks J, Islam KS, ... Dolgalev I, et al. Innate αβ T cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming. Cancer Discovery. PMID 31266770 DOI: 10.1158/2159-8290.Cd-19-0161 |
0.361 |
|
| 2019 |
Wang L, Yang H, Zamperone A, Diolaiti D, Palmbos PL, Abel EV, Purohit V, Dolgalev I, Rhim AD, Ljungman M, Hadju CH, Halbrook CJ, Bar-Sagi D, di Magliano MP, Crawford HC, et al. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Genes & Development. PMID 31048544 DOI: 10.1101/Gad.323303.118 |
0.353 |
|
| 2019 |
Tikhonova AN, Dolgalev I, Hu H, Sivaraj KK, Hoxha E, Cuesta-Domínguez Á, Pinho S, Akhmetzyanova I, Gao J, Witkowski M, Guillamot M, Gutkin MC, Zhang Y, Marier C, Diefenbach C, et al. The bone marrow microenvironment at single-cell resolution. Nature. PMID 30971824 DOI: 10.1038/S41586-019-1104-8 |
0.662 |
|
| 2019 |
Tetz G, Vikina D, Brown S, Zappile P, Dolgalev I, Tsirigos A, Heguy A, Tetz V. Draft Genome Sequence of Streptococcus halitosis sp. nov., Isolated from the Dorsal Surface of the Tongue of a Patient with Halitosis. Microbiology Resource Announcements. 8. PMID 30701262 DOI: 10.1128/MRA.01704-18 |
0.453 |
|
| 2019 |
Deng J, Thennavan A, Pan Y, Dolgalev I, Chen T, Silver H, Harris M, Pyon V, Li F, Lee C, Tsirigos A, Rothenberg E, Perou CM, Wong K. Abstract 3223: Overcome LKB1 mutated cancer resistance to anti-PD1 treatment Cancer Research. 79: 3223-3223. DOI: 10.1158/1538-7445.Am2019-3223 |
0.575 |
|
| 2019 |
Witkowski M, Dolgalev I, Evensen N, Roberts K, Sreeram S, Dai Y, Tikhonova A, Loomis C, Mullighan C, Tsirigos A, Carroll W, Aifantis I. 2029 - THE RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IMMUNE MICROENVIRONMENT Experimental Hematology. 76: S49. DOI: 10.1016/J.Exphem.2019.06.301 |
0.674 |
|
| 2018 |
Adeegbe DO, Liu S, Hattersley M, Bowden M, Zhou CW, Li S, Vlahos R, Grondine M, Dolgalev I, Ivanova E, Quinn MM, Gao P, Hammerman PS, Bradner JE, Diehl JA, et al. BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer. Cancer Immunology Research. PMID 30087114 DOI: 10.1158/2326-6066.Cir-18-0077 |
0.577 |
|
| 2018 |
Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton SL, Zagzag D, Chiriboga L, Gardner SL, et al. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nature Communications. 9: 2868. PMID 30030436 DOI: 10.1038/S41467-018-05029-3 |
0.352 |
|
| 2018 |
Cui X, Morales RT, Qian W, Wang H, Gagner JP, Dolgalev I, Placantonakis D, Zagzag D, Cimmino L, Snuderl M, Lam RHW, Chen W. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials. 161: 164-178. PMID 29421553 DOI: 10.1016/J.Biomaterials.2018.01.053 |
0.341 |
|
| 2018 |
Sen R, Dolgalev I, Bayin NS, Heguy A, Tsirigos A, Placantonakis DG. Single-Cell RNA Sequencing of Glioblastoma Cells. Methods in Molecular Biology (Clifton, N.J.). 1741: 151-170. PMID 29392698 DOI: 10.1007/978-1-4939-7659-1_12 |
0.575 |
|
| 2018 |
Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, Dolgalev I, Clementi C, Tsirigos A, Erlebacher A. H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. The Journal of Clinical Investigation. 128: 233-247. PMID 29202469 DOI: 10.1172/Jci95937 |
0.53 |
|
| 2018 |
Romero R, Sayin VI, Shawn DM, Bauer M, Singh SX, LeBoeuf S, Karakousi TR, Ellis DC, Bhutkar A, Sanchez-Rivera F, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Dolgalev I, et al. Abstract A43: Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-A43 |
0.35 |
|
| 2017 |
Fanok MH, Sun A, Fogli LK, Narendran V, Eckstein M, Kannan K, Dolgalev I, Lazaris C, Heguy A, Laird ME, Sundrud MS, Liu C, Kutok J, Lacruz RS, Latkowski JA, et al. Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma. The Journal of Investigative Dermatology. PMID 29128259 DOI: 10.1016/J.Jid.2017.10.028 |
0.577 |
|
| 2017 |
Brown JA, Yonekubo Y, Hanson N, Sastre-Perona A, Basin A, Rytlewski JA, Dolgalev I, Meehan S, Tsirigos A, Beronja S, Schober M. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. Cell Stem Cell. 21: 650-664.e8. PMID 29100014 DOI: 10.1016/J.Stem.2017.10.001 |
0.586 |
|
| 2017 |
Tetz G, Vecherkovskaya M, Zappile P, Dolgalev I, Tsirigos A, Heguy A, Tetz V. Complete Genome Sequence of Kluyvera intestini sp. nov., Isolated from the Stomach of a Patient with Gastric Cancer. Genome Announcements. 5. PMID 29074664 DOI: 10.1128/Genomea.01184-17 |
0.51 |
|
| 2017 |
Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. 8: 64932-64953. PMID 29029402 DOI: 10.18632/Oncotarget.18117 |
0.582 |
|
| 2017 |
Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Dolgalev I, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nature Medicine. PMID 28967920 DOI: 10.1038/Nm.4407 |
0.353 |
|
| 2017 |
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. PMID 28823558 DOI: 10.1016/J.Cell.2017.07.032 |
0.675 |
|
| 2017 |
Cerrone M, Montnach J, Lin X, Zhao YT, Zhang M, Agullo-Pascual E, Leo-Macias A, Alvarado FJ, Dolgalev I, Karathanos TV, Malkani K, Van Opbergen CJM, van Bavel JJA, Yang HQ, Vasquez C, et al. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm. Nature Communications. 8: 106. PMID 28740174 DOI: 10.1038/S41467-017-00127-0 |
0.326 |
|
| 2017 |
Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. PMID 28586758 DOI: 10.18632/oncotarget.18117 |
0.54 |
|
| 2016 |
Strikoudis A, Lazaris C, Trimarchi T, Galvao Neto AL, Yang Y, Ntziachristos P, Rothbart S, Buckley S, Dolgalev I, Stadtfeld M, Strahl BD, Dynlacht BD, Tsirigos A, Aifantis I. Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a. Nature Cell Biology. PMID 27749823 DOI: 10.1038/Ncb3424 |
0.663 |
|
| 2016 |
Hanniford D, Martinez CN, Dolgalev I, Lattanzi MW, Vega-Saenz de Miera E, Robinson EM, Goldman C, Heguy A, Kirchhoff T, Osman I, Hernando E. Targeted next-generation sequencing of melanoma patient samples to reveal mutations in non-protein coding regions of targetable oncogenes. Journal of Clinical Oncology. 34: 9559-9559. DOI: 10.1200/Jco.2016.34.15_Suppl.9559 |
0.337 |
|
| 2016 |
Saliba J, Evensen NA, Meyer J, Dolgalev I, Newman D, Chowdhury A, Nersting J, Wang J, Schmiegelow K, Carroll WL. Using Whole Exome Sequencing in Pediatric Acute Lymphoblastic Leukemia Germline, Diagnosis, and Relapse Trios to Discover Novel Relapse Enriched Mutations for Clonal Backtracking By Ddpcr Blood. 128: 4085-4085. DOI: 10.1182/Blood.V128.22.4085.4085 |
0.368 |
|
| 2016 |
Frenster J, Bayin NS, Kane JR, Rubenstein J, Modrek A, Baitamal R, Dolgalev I, Rudzenski K, Snuderl M, Golfinos J, Doyle W, Pacione D, Chi A, Heguy A, Shohdy N, et al. STMC-25. GPR133 PROMOTES HYPOXIA-DRIVEN TUMOR PROGRESSION IN GLIOBLASTOMA Neuro-Oncology. 18: vi187-vi188. DOI: 10.1093/Neuonc/Now212.788 |
0.324 |
|
| 2015 |
Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, ... ... Dolgalev I, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discovery. PMID 26566875 DOI: 10.1182/Blood.V126.23.481.481 |
0.33 |
|
| 2015 |
Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Research. 75: 264-9. PMID 25488749 DOI: 10.1158/0008-5472.Can-14-1008 |
0.325 |
|
| 2015 |
Schatz JH, Horwitz SM, Teruya-Feldstein J, Lunning MA, Viale A, Huberman K, Socci ND, Lailler N, Heguy A, Dolgalev I, Migliacci JC, Pirun M, Palomba ML, Weinstock DM, Wendel HG. Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. Leukemia. 29: 237-41. PMID 25257991 DOI: 10.1038/Leu.2014.261 |
0.322 |
|
| 2015 |
Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner SL, Allen JC, Wisoff JH, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister SM, et al. Abstract LB-172: Novel candidate oncogenic drivers in pineoblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-172 |
0.358 |
|
| 2015 |
Bayin NS, Sen R, Si S, Modrek AS, Ortenzi V, Zagzag D, Snuderl M, Golfinos JG, Doyle W, Galifianakis N, Chesler M, Illa-Bochaca I, Barcellos-Hoff MH, Dolgalev I, Heguy A, et al. STEM-04DEFINING GLIOBLASTOMA STEM CELL HETEROGENEITY Neuro-Oncology. 17: v208.4-v209. DOI: 10.1093/Neuonc/Nov234.04 |
0.383 |
|
| 2015 |
Karajannis M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. GENO-20NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: v95.4-v96. DOI: 10.1093/Neuonc/Nov215.20 |
0.347 |
|
| 2015 |
Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. MB-17 * NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: iii23-iii23. DOI: 10.1093/Neuonc/Nov061.93 |
0.345 |
|
| 2014 |
Di Micco R, Fontanals-Cirera B, Low V, Ntziachristos P, Yuen SK, Lovell CD, Dolgalev I, Yonekubo Y, Zhang G, Rusinova E, Gerona-Navarro G, Cañamero M, Ohlmeyer M, Aifantis I, Zhou MM, et al. Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes. Cell Reports. 9: 234-47. PMID 25263550 DOI: 10.1016/J.Celrep.2014.08.055 |
0.665 |
|
| 2014 |
Paoluzzi L, Hanniford D, Sokolova E, Dolgalev I, Heguy A, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. Preclinical testing supports combined BET and BRAF inhibition as a promising therapeutic strategy for melanoma. Journal of Clinical Oncology. 32: 9072-9072. DOI: 10.1200/Jco.2014.32.15_Suppl.9072 |
0.306 |
|
| 2014 |
Sumru Bayin N, Si S, Modrek A, Song H, Zagzag D, Hoang DM, Wadghiri YZ, Dolgalev I, Baysan M, Heguy A, Barcellos-Hoff MH, Placantonakis D. SC-04 * NON-UNIFORM NOTCH SIGNALING UNDERLIES HETEROGENEITY WITHIN THE GLIOBLASTOMA STEM CELL POPULATION Neuro-Oncology. 16: v197-v197. DOI: 10.1093/Neuonc/Nou275.4 |
0.352 |
|
| 2013 |
Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, et al. The integrated landscape of driver genomic alterations in glioblastoma. Nature Genetics. 45: 1141-9. PMID 23917401 DOI: 10.1038/Ng.2734 |
0.359 |
|
| 2013 |
Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, et al. The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 45: 791-8. PMID 23685749 DOI: 10.1038/Ng.2643 |
0.356 |
|
| 2013 |
Schatz JH, Horwitz SM, Lunning MA, Dolgalev I, Huberman K, Heguy A, Viale A, Socci ND, Pirun M, Teruya-Feldstein J, Wendel H. Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified Blood. 122: 843-843. DOI: 10.1182/Blood.V122.21.843.843 |
0.399 |
|
| 2012 |
Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, She QB, Gallardo H, Liu C, Merghoub T, Hefter B, Dolgalev I, Viale A, Heguy A, De Stanchina E, Cobrinik D, et al. Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene. 31: 446-57. PMID 21725359 DOI: 10.1038/Onc.2011.250 |
0.39 |
|
| 2010 |
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 18: 11-22. PMID 20579941 DOI: 10.1016/J.Ccr.2010.05.026 |
0.313 |
|
| 2010 |
Xing F, Persaud Y, Pratilas C, Janakiraman M, She Q, Liu C, Dolgalev I, Heguy A, Wolchok J, Cobrinik D, Houghton A, Taylor B, Rosen N, Solit D. Abstract 1971: Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations Cancer Research. 70: 1971-1971. DOI: 10.1158/1538-7445.Am10-1971 |
0.362 |
|
| 2009 |
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 114: 144-7. PMID 19420352 DOI: 10.1182/Blood-2009-03-210039 |
0.326 |
|
| 2009 |
Xing F, Persaud Y, Pratilas C, Janakiraman M, She Q, Liu C, Dolgalev I, Heguy A, Wolchok J, Cobrinik D, Houghton A, Taylor B, Rosen N, Solit D. Abstract B87: Genomic complexity and BRAF/MEK‐dependence in V600E BRAF mutant melanoma Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B87 |
0.372 |
|
| 2007 |
Heguy A, Harvey BG, Leopold PL, Dolgalev I, Raman T, Crystal RG. Responses of the human airway epithelium transcriptome to in vivo injury Physiological Genomics. 29: 139-148. PMID 17164391 DOI: 10.1152/Physiolgenomics.00167.2006 |
0.306 |
|
| Show low-probability matches. |